36 results
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
as a result of hiring additional R&D personnel, as well as certain pay increases for existing R&D personnel, which represented 26% of the increase in research … period was primarily due to a $369,000 increase in salaries as a result of hiring additional personnel and certain pay raises for existing personnel
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
as a result of hiring additional personnel and certain pay increases for existing personnel, which represents 27% of the increase in the research … due to a $279,000 increase in salaries as a result of hiring additional personnel and certain pay raises for existing personnel, a $580,000 increase
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
27 May 22
Condensed Consolidated Financial Statements
4:39pm
to a $605,000 increase in salaries as a result of hiring additional personnel and certain pay increases for existing personnel, a $960,000 increase in expenses … of 2022 as compared to the 2021 period was primarily due to a $81,000 increase in salaries as a result of hiring additional personnel and certain pay
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
4 Apr 23
Enlivex Announces Tislelizumab Clinical Collaboration, Full Year 2022 Financial Results, and Provides Business Updates
8:05am
in salaries as a result of hiring additional R&D personnel and certain pay increases for existing R&D personnel .
General and administrative expenses … manufactured and inventoried, as well as from an increase in salaries as a result of hiring additional R&D personnel and certain pay increases for existing R
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Dec 22
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
8:05am
of hiring additional R&D personnel and certain pay increases for existing R&D personnel.
General and administrative expenses were $1.5 million … of Allocetra TM doses that were manufactured and inventoried, as well as from an increase in salaries as a result of hiring additional R&D personnel
6-K
nwtho0e8ybj
2 Aug 21
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant
8:02am
6-K
EX-99.1
qxi0p65e8m66wig7
2 Aug 21
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant
8:02am
6-K
EX-99.2
xy65fw
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.2
6fa5rxxd7z7n5ec1x 8r
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.3
umuraebuponpmhs
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.2
et3ngefr4n108it
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
lcqbcju 3grsdz
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
8xbjigm32j49c4gsb05
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
qyzpbjp5nxik y90p
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.2
l8xy6w99a n2x
20 May 19
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
d3vwo87vi 9r
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
kcgr7ct xps
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
eyg02z
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
6znv8 aifb2q
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm